Krystal Biotech, Inc. — Director's Dealing 2017

Sep 20, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2017-09-19

Reporting Person: Krishnan Suma (Director, Chief Operating Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1835249	Direct
Common Stock	1835249	Indirect
Series A Convertible Preferred Stock	112162	Indirect

Footnotes

F1: Reflects 1,835,249 shares of common stock owned by Krish S. Krishnan, the spouse of the reporting person.

F2: The Series A convertible preferred stock will automatically convert on a one-to-one basis into 112,162 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.

F3: The Krishnan Family Trust beneficially owns 112,162 shares of Series A convertible preferred stock. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.